Editorial: Advances in the medical management of infantile hemangioma DOI Creative Commons
Haiwei Wu, Yi Ji, Jiawei Zheng

et al.

Frontiers in Oncology, Journal Year: 2023, Volume and Issue: 13

Published: June 16, 2023

EDITORIAL article Front. Oncol., 16 June 2023Sec. Pediatric Oncology Volume 13 - 2023 | https://doi.org/10.3389/fonc.2023.1229197

Language: Английский

Insights into the mechanisms of angiogenesis in infantile hemangioma DOI Open Access
Shanshan Xiang, Xue Gong, Tong Qiu

et al.

Biomedicine & Pharmacotherapy, Journal Year: 2024, Volume and Issue: 178, P. 117181 - 117181

Published: July 25, 2024

Language: Английский

Citations

12

Infantile hemangioma models: is the needle in a haystack? DOI Creative Commons
Meng Kong, Yanan Li, Kai Wang

et al.

Journal of Translational Medicine, Journal Year: 2023, Volume and Issue: 21(1)

Published: May 6, 2023

Abstract Infantile hemangioma (IH) is the most prevalent benign vascular tumor in infants, with distinct disease stages and durations. Despite fact that majority of IHs can regress spontaneously, a small percentage cause disfigurement or even be fatal. The mechanisms underlying development IH have not been fully elucidated. Establishing stable reliable models provides standardized experimental platform for elucidating its pathogenesis, thereby facilitating new drugs identification effective treatments. Common include cell suspension implantation model, viral gene transfer tissue block transplantation recent three-dimensional (3D) microtumor model. This article summarizes research progress clinical utility various models, as well benefits drawbacks each. Researchers should select based on their individual objectives to achieve anticipated objectives, increasing relevance findings.

Language: Английский

Citations

12

PFKFB3 in neovascular eye disease: unraveling mechanisms and exploring therapeutic strategies DOI Creative Commons
Peiyu Liu, Dandan Sun, Shuchang Zhang

et al.

Cell & Bioscience, Journal Year: 2024, Volume and Issue: 14(1)

Published: Feb. 10, 2024

Abstract Background Neovascular eye disease is characterized by pathological neovascularization, with clinical manifestations such as intraocular exudation, bleeding, and scar formation, ultimately leading to blindness in millions of individuals worldwide. Pathologic ocular angiogenesis often occurs common fundus diseases including proliferative diabetic retinopathy (PDR), age-related macular degeneration (AMD), prematurity (ROP). Anti-vascular endothelial growth factor (VEGF) targets the core pathology angiogenesis. Main body In recent years, therapies targeting metabolism prevent have also rapidly developed, offering assistance patients a poor prognosis while receiving anti-VEGF therapy reducing side effects associated long-term VEGF usage. Phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3), key enzyme targeted metabolism, has been shown great potential, antiangiogenic multiple protective treatment neovascular disease. this review, we summarize mechanisms types diseases; discuss effect potential mechanism PFKFB3, related inhibitors PFKFB3; look forward future exploration directions therapeutic prospects PFKFB3 Conclusion disease, most severely debilitating retinal largely incurable, necessitating new methods. possess various treating With development several drugs their gradual entry into research, PFKFB3-mediated glycolysis emerged promising approach for

Language: Английский

Citations

5

Feature Gene Selection and Functional Validation of SH3KBP1 in Infantile Hemangioma Using Machine Learning DOI
Jiu Yin,

Hang Gou,

Jian Qi

et al.

Biochemical and Biophysical Research Communications, Journal Year: 2025, Volume and Issue: 752, P. 151469 - 151469

Published: Feb. 10, 2025

Language: Английский

Citations

0

Glycometabolic Regulation of Angiogenesis: Mechanisms and Therapeutic Strategies DOI Open Access
Zhifeng Yao, Junting Li,

Jiaming Yu

et al.

International Journal of Molecular Sciences, Journal Year: 2025, Volume and Issue: 26(6), P. 2386 - 2386

Published: March 7, 2025

Angiogenesis, the process by which new blood vessels emerge from pre-existing vasculature, forms fundamental biological basis for therapeutic angiogenesis. In recent years, this field has garnered significant attention, particularly in context of understanding mechanisms angiogenesis through lens glycometabolism. The potential clinical applications research have been widely acknowledged within medical community. article, role and principal molecular that govern it are first delineated. influence glycometabolism on is then explored, with a focus glycolysis. Finally, based regulation presented, offering novel perspectives ongoing applications.

Language: Английский

Citations

0

Insights into the mechanisms of angiogenesis in hepatoblastoma DOI Creative Commons
Meng Kong,

Yunpeng Zhai,

Hongzhen Liu

et al.

Frontiers in Cell and Developmental Biology, Journal Year: 2025, Volume and Issue: 13

Published: May 14, 2025

Hepatoblastoma (HB), the most common pediatric liver malignancy, is characterized by aggressive growth and metastasis driven complex angiogenic mechanisms. This review elucidates pivotal role of angiogenesis in HB progression, emphasizing metabolic reprogramming, tumor microenvironment (TME) dynamics, oncogenic signalling pathways. The Warburg effect cells fosters a hypoxic microenvironment, stabilizing hypoxia-inducible factor-1α (HIF-1α) upregulating vascular endothelial factor (VEGF), which synergistically enhances angiogenesis. Key pathways such as Wnt/β-catenin, VEGF, PI3K/AKT, JAK2/STAT3 are central to cell proliferation, migration, maturation, whereas interactions with tumor-associated macrophages (TAMs) pericytes further remodel TME support neovascularization. Long noncoding RNAs glycolytic enzymes have emerged critical regulators angiogenesis, linking activity expansion. Anti-angiogenic therapies, including VEGF inhibitors pathway-targeting agents, show preclinical promise but face challenges resistance off-target effects. Future directions advocate for dual-target strategies, spatial multiomics technologies map metabolic–angiogenic crosstalk, personalized approaches leveraging biomarkers risk stratification. synthesis underscores need interdisciplinary collaboration translate mechanistic insights into durable ultimately improving outcomes patients.

Language: Английский

Citations

0

Propranolol accelerates adipogenesis and inhibits endothelium differentiation of HemSCs via suppressing HK2 mediated glycolysis DOI

Tianshuang Zhu,

Peipei Wang,

Rong Wang

et al.

Pediatric Research, Journal Year: 2025, Volume and Issue: unknown

Published: May 17, 2025

Language: Английский

Citations

0

Changes and Significance of Central Carbon Metabolism before and after Metformin Treatment of Type 2 Diabetes Based on Mass Spectrometry DOI Creative Commons
Yang Shu,

Fujie Yang,

Weidong Li

et al.

Discovery Medicine, Journal Year: 2024, Volume and Issue: 36(183), P. 678 - 678

Published: Jan. 1, 2024

An imbalance in energy metabolism serves as a causal factor for type 2 diabetes (T2D). Although metformin has been known to ameliorate the overall imbalance, but direct correlation between and central carbon (CCM) not thoroughly investigated. In this study, we employed high-performance ion chromatography-tandem mass spectrometry (HPIC-MS/MS) technique examine alterations significance of CCM both before after treatment T2D.

Language: Английский

Citations

3

The Role of Natural Extracts in the Management of Infantile Hemangiomas and Vascular Tumors DOI Creative Commons
Iulia Cristina Roca, Elena Cojocaru, Daniela Rusu

et al.

Pediatric Health Medicine and Therapeutics, Journal Year: 2024, Volume and Issue: Volume 15, P. 1 - 16

Published: Jan. 1, 2024

Abstract: Hemangiomas are vascular tumors resulting from the proliferation of endothelial-like cells; they most common childhood tumors, affecting approximately 5– 10% newborns and infants. Besides hemangiomas, which definitely benign despite their overgrowth potential, there other like hemangioendotheliomas, may display intermediate characteristics between hemangiomas highly malignant angiosarcomas. Standard therapy be constricted by serious adverse effects, high cost, or traumatic influence. Diet is a major resource for health preservation, disease prevention, treatment. The therapeutic property edible berries, marine products, medicinal plants have long been known used in traditional medicine; plant-based nutrition can prevent development progression diseases associated with extensive neo-vascularization. purpose our review to highlight those natural treatments that hemangioma tumor patients receive future, both benefit families. We performed according Preferred Reporting Items Systematic Reviews Metanalysis Statement. Web Science, PubMed, EMBASE engines study, searched association naturopathic treatment/plant extract/plants published articles. found extracts fruits cost-effective safe as well forms cancer. In any case, more vitro vivo studies needed confirm proposed signaling pathways validate improvement parameters after products administration. era molecularly targeted personalized medicine approaching naturally occurring substances very useful tools treatment prevention. Plant extract strong specificity pertinence, non- toxic few side become an emerging cancer Keywords: abnormalities, plants, plant extract,

Language: Английский

Citations

2

PFKFB3 regulated the growth and migration of ovarian cancer cells DOI

Ye Cheng,

Ping Wang, Lidan Liu

et al.

Journal of Environmental Pathology Toxicology and Oncology, Journal Year: 2024, Volume and Issue: 43(4), P. 53 - 64

Published: Jan. 1, 2024

Ovarian cancer is one of the most common malignant tumors in female reproductive organs. Its incidence rate second only to uterine body and cervical cancer, posing a serious threat women's health. Herein, we explored that PFKFB3 progression ovarian its underlying mechanism. All serum samples from were collected by our hospital. mRNA expressions patients with cell lines up-regulated. protein cells induced. high PFKFB3expression had lower survival rate. The PFKFB3gene promoted proliferation EDU cells, increased metastasis cancer. Si-PFKFB3 reduced decreased gene up-regulation caspase-3/9 activity levels also Warburg effect NLRP3-induced pyroptosis suppressed NLRP3 expression. was target spot for on Taken together, conclude axis reduce increase provide molecular insight into mechanisms which regulates

Language: Английский

Citations

2